Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 163
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
Interview | George Tziras, Small Pharma
Combating Suicidality: A Role for Psilocybin and Ayahuasca?
PT361 – Jason Slot, Ph.D. – Mycology and Evolutionary Genomics
Silo Pharma Initiates FDA Pre-Investigational New Drug (IND) Package for Time-Released...
Reunion Neuroscience to Participate in the Cantor Neurology & Psychiatry Conference
Silo Pharma Announces Closing of $5.75 Million Public Offering of Common...
Psychedelic Bulletin #119: More Misery for MindMed; Another Psychedelics Co. Ceases...
Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder...
Whole-Body Effects of Psychedelics Part 3 – The Heart
Psyence Group Completes Export of Psilocybin Mushrooms to Portugal
Load more